WendyS.RubinsteinMDPhD

Medical Genetics • Silver Spring, MD

Clinical Genetics, Clinical Molecular Genetics

Director, Personalized Medicine, FDA

Join to view full profile

Dr. Rubinstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rubinstein's full profile

Already have an account?

Office
Food and Drug Administration
Center for Devices and Radiological Health
Silver Spring, MD 20993

Education & Training

UPMC Medical EducationResidency, Medical Genetics and Genomics, 1994 - 1996
University of RochesterResidency, Internal Medicine, 1989 - 1992
Icahn School of Medicine at Mount SinaiClass of 1989
City University of New York / Mount Sinai School of MedicinePhD, Biomedical Sciences, Medical Scientist Training Program, 1983 - 1987

Certifications & Licensure

VA State Medical License 2018 - 2024
IL State Medical License 2001 - 2020
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics

Awards, Honors, & Recognition

NIH Director’s Award National Institutes of Health, 2012
National Library of Medicine Special Services Award National Library of Medicine, 2012
Fellow American College of Physicians, 2006
Fellow American College of Medical Genetics, 1996
Join now to see all

Clinical Trials

Evaluating Tools for Health Promotion and Disease Prevention Start of enrollment: 2005 Sep 01
Completed
Phase 1

Publications & Presentations

PubMed

71 citations
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
A. Mitra, Elizabeth Bancroft, Yolanda Barbachano, Elizabeth Page, Christopher S. Foster
BJU International. 2011-01-01
137 citations
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant
Jun Li, Susan L. Woods, Sue Healey, Jonathan Beesley, Xiaoqing Chen
American Journal of Human Genetics. 2016-05-05
1277 citations
Mutations in SDHD, a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Bora E. Baysal, Robert E. Ferrell, Joan E. Willett-Brozick, Elizabeth C. Lawrence, David Myssiorek
Science. 2000-02-04

Lectures

Characteristics of patients receiving immune checkpoint inhibitors (ICI) in ASCOâ€™s CancerLinQ.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

First Ever Genetic Test for Fragile X SyndromeFebruary 21st, 2020
CancerLinQ Leader Contributes to New BRCA Exchange to Inform Understanding of Cancer RiskJanuary 9th, 2019
New JOP Article Highlights Challenges Oncologists Face Due to a Lack of Interoperability and How CancerLinQ® Can HelpDecember 19th, 2018
Join now to see all

External Links

NIH Genetic Testing Registryhttp://www.ncbi.nlm.nih.gov/gtr/
LinkedIn Profilehttp://www.linkedin.com/in/wrubinstein/